Abingdon Health Plc (AIM:ABDX)

Market Cap	34.81M +3.0%
Revenue (ttm)	10.99M +30.4%
Net Income	-2.13M
EPS	-0.01
Shares Out	435.07M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100,665
Open	8.75
Previous Close	8.75
Day's Range	8.00 - 9.00
52-Week Range	5.50 - 13.00
Beta	0.02
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 15, 2026

About Abingdon Health

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company also engages in manufacturing of lateral flow devices; and provision of support in meeting compliance requirements in international IVD and medical device markets. Its diagnostic products include PCRD: Nucleic acid lateral flow, a rapid, portable nucleic acid detection; Abi...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 2008
• Employees: 131
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ABDX

Financial Performance

In fiscal year 2026, Abingdon Health's revenue was 10.99 million, an increase of 30.42% compared to the previous year's 8.43 million. Losses were -2.13 million, -37.69% less than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 12, 2026

Data Sources Report a data error